Lab
Pathology Associates Laboratory of Southern California
Pathology Associates Laboratory of Southern California was paid $121K by Medicaid between Jan 2018 and Oct 2024, across 41 billing codes. Its largest line is 87798, Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism — 37% of everything it billed.
33Billing provider infoPATHOLOGY ASSOCIATES LABORATORY OF SOUTHERN CALIFORNIA
ANAHEIM, CA 92801
ANAHEIM, CA 92801
33aNPI1598191512assigned 09/23/2013
33bProvider typeClinical Medical Laboratory
28Total paid$121K
24GClaims27,500
24DCodes billed41
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in California
Rank by total paid#319 of 561
Median peer was paid$222K
This provider vs. median0.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,871 | $38K | |
| 2019 | 430 | $899.49 | |
| 2020 | 3,134 | $62K | |
| 2021 | 4,928 | $14K | |
| 2022 | 2,325 | $3K | |
| 2023 | 8,125 | $432.67 | |
| 2024incomplete | 4,687 | $3K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 37% | 5,143 | 4,644 | $45K |
| 87507 | 15% | 1,379 | 1,295 | $18K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 15% | 838 | 755 | $18K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 5.6% | 165 | 164 | $7K |
| 87486 | 3.3% | 1,843 | 1,715 | $4K | |
| 87581 | 2.9% | 1,843 | 1,715 | $4K | |
| 87631 | 2.9% | 1,146 | 1,136 | $3K | |
| 87632 | 2.4% | 89 | 89 | $3K | |
| 87186 | 1.7% | 121 | 89 | $2K | |
| 87541 | 1.5% | 984 | 949 | $2K | |
| 87150 | 1.3% | 966 | 959 | $2K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1.2% | 70 | 70 | $1K |
29 more codes
| 86003 | 1.1% | 95 | $1K | |
| 86008 | <1% | 148 | $956.36 | |
| 87500 | <1% | 1,497 | $816.07 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 189 | $757.66 |
| 87641 | <1% | 3,048 | $739.24 | |
| 87481 | <1% | 1,721 | $728.20 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 123 | $675.00 |
| 87640 | <1% | 1,446 | $627.21 | |
| 87652 | <1% | 490 | $610.80 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 493 | $563.74 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 28 | $468.27 |
| 87634 | <1% | 219 | $449.28 | |
| 80061 | Lipid panel | <1% | 56 | $415.20 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 449 | $342.50 |
| 80053 | Comprehensive metabolic panel | <1% | 58 | $308.22 |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 218 | $306.56 |
| 87529 | <1% | 228 | $273.69 | |
| 99000 | <1% | 114 | $272.50 | |
| 87505 | <1% | 55 | $228.08 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 48 | $209.09 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 75 | $200.00 |
| 87653 | <1% | 1,091 | $180.56 | |
| 87498 | <1% | 220 | $171.26 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 123 | $105.68 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 13 | $85.34 |
| 82785 | <1% | 183 | $78.84 | |
| 87482 | <1% | 87 | $44.59 | |
| 99072 | <1% | 25 | $24.16 | |
| 87101 | 0% | 373 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBU, XIANGDONG (DIRECTOR)